ImmunityBio Inc., in partnership with NantWorks, will host the inaugural U.S.-Saudi Biotech Alliance Summit on January 14, 2026, in San Francisco. The summit will bring together leaders from the United States and Saudi Arabia to accelerate innovation in immunotherapy, AI-enabled biomanufacturing, and global health security. The event will feature keynote addresses, panel discussions, and sessions focused on scientific and technological advances in healthcare.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybio Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260112462615) on January 12, 2026, and is solely responsible for the information contained therein.